• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在新冠疫情期间,基础疾病会增加患长期新冠的风险。

Preexisting symptoms increase the risk of developing long COVID during the SARS-CoV-2 pandemic.

作者信息

Lak Vincent, Sjöland Helen, Adiels Martin, Lundberg Christina E, Robertson Josefina, Åberg Maria, Alex Christian, Lindgren Martin, Rosengren Annika

机构信息

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Medicine Geriatrics and Emergency Medicine, Sahlgrenska University Hospital, Östra Hospital, Region Västra Götaland, Gothenburg, Sweden.

出版信息

J Intern Med. 2025 Aug;298(2):107-122. doi: 10.1111/joim.20102. Epub 2025 Jun 4.

DOI:10.1111/joim.20102
PMID:40464158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12239058/
Abstract

BACKGROUND

Long COVID is defined as otherwise unexplained symptoms following a SARS-CoV-2 infection.

OBJECTIVE

To examine the prevalence of preexisting symptoms compatible with long COVID in individuals with a diagnosis of long COVID.

METHODS

This retrospective, observational study included the adult population (aged 18 years and older) in Region Västra Götaland, with at least one recorded healthcare contact between January 1, 2020, and November 30, 2023, from a regional database comprising all levels of healthcare contacts. Data on long COVID, relevant symptoms before and after the pandemic started (2016-2023), and SARS-CoV-2 infection status were extracted using the International Classification of Diseases version 10 (ICD-10) codes. Individuals who had been hospitalized due to a SARS-CoV-2 infection were considered separately.

RESULTS

Out of 1,415,885 individuals, 9202 (0.6%) had been diagnosed with long COVID. Among the non-hospitalized individuals, the record of at least one of the relevant symptoms was more common in those with long COVID compared to those without it (57.6% vs. 36.3% for men and 71.6% vs. 50.4% for women), already before January 1, 2020. Among individuals with any relevant symptom, the odds ratios (ORs) of having long COVID were OR = 2.28 (95% confidence interval [CI] = 2.10-2.48) for men and OR = 2.32 (95% CI = 2.18-2.48 for women) after adjusting for age group, obesity, asthma, and anxiety, compared with individuals without any relevant symptom.

CONCLUSIONS

Individuals diagnosed with long COVID had more healthcare contacts for relevant symptoms even before the pandemic compared to individuals without long COVID.

摘要

背景

长期新冠被定义为新型冠状病毒感染后出现的无法用其他原因解释的症状。

目的

研究确诊为长期新冠的个体中与长期新冠相符的既往症状的患病率。

方法

这项回顾性观察性研究纳入了西约塔兰地区的成年人群(18岁及以上),这些个体在2020年1月1日至2023年11月30日期间至少有一次医疗接触记录,数据来自一个包含各级医疗接触的区域数据库。使用国际疾病分类第10版(ICD-10)编码提取关于长期新冠、疫情开始前(2016 - 2023年)和之后的相关症状以及新型冠状病毒感染状况的数据。因新型冠状病毒感染住院的个体单独进行考虑。

结果

在1,415,885名个体中,9202人(0.6%)被诊断为长期新冠。在未住院的个体中,与未患长期新冠的个体相比,至少有一种相关症状的记录在患长期新冠的个体中更为常见(男性为57.6%对36.3%,女性为71.6%对50.4%),甚至在2020年1月1日之前就是如此。在有任何相关症状的个体中,与没有任何相关症状的个体相比,在调整年龄组、肥胖、哮喘和焦虑因素后,男性患长期新冠的比值比(OR)为OR = 2.28(95%置信区间[CI] = 2.10 - 2.48),女性为OR = 2.32(95% CI = 2.18 - 2.48)。

结论

与未患长期新冠的个体相比,确诊为长期新冠的个体在疫情之前就因相关症状有更多的医疗接触。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/9b3cdc0a5faa/JOIM-298-107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/c1d9a2fc4ab9/JOIM-298-107-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/46d336cdee51/JOIM-298-107-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/a1f266d25e4f/JOIM-298-107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/83916191051f/JOIM-298-107-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/0b13559c3765/JOIM-298-107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/9b3cdc0a5faa/JOIM-298-107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/c1d9a2fc4ab9/JOIM-298-107-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/46d336cdee51/JOIM-298-107-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/a1f266d25e4f/JOIM-298-107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/83916191051f/JOIM-298-107-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/0b13559c3765/JOIM-298-107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cb4/12239058/9b3cdc0a5faa/JOIM-298-107-g001.jpg

相似文献

1
Preexisting symptoms increase the risk of developing long COVID during the SARS-CoV-2 pandemic.在新冠疫情期间,基础疾病会增加患长期新冠的风险。
J Intern Med. 2025 Aug;298(2):107-122. doi: 10.1111/joim.20102. Epub 2025 Jun 4.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults.儿童和青年人群 SARS-CoV-2 感染的体重指数与感染后后遗症。
JAMA Netw Open. 2024 Oct 1;7(10):e2441970. doi: 10.1001/jamanetworkopen.2024.41970.
4
Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021.埃塞俄比亚2019冠状病毒病抗体血清流行率:2021年全国人口调查结果
PLoS One. 2025 May 6;20(5):e0313791. doi: 10.1371/journal.pone.0313791. eCollection 2025.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
7
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
8
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.
9
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
10
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.

本文引用的文献

1
How do clinicians use post-COVID syndrome diagnosis? Analysis of clinical features in a Swedish COVID-19 cohort with 18 months' follow-up: a national observational cohort and matched cohort study.临床医生如何进行新冠后综合征的诊断?对瑞典一个有18个月随访期的新冠病毒疾病队列的临床特征分析:一项全国性观察性队列和匹配队列研究。
BMJ Public Health. 2024 Mar 25;2(1):e000336. doi: 10.1136/bmjph-2023-000336. eCollection 2024 Jun.
2
Long COVID: a clinical update.长新冠:临床更新。
Lancet. 2024 Aug 17;404(10453):707-724. doi: 10.1016/S0140-6736(24)01136-X. Epub 2024 Jul 31.
3
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.
新冠病毒感染后急性期到德尔塔和奥密克戎变异株流行时期的后遗症。
N Engl J Med. 2024 Aug 8;391(6):515-525. doi: 10.1056/NEJMoa2403211. Epub 2024 Jul 17.
4
Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study.长新冠患者的医疗保健利用情况:一项 OpenSAFELY 队列研究。
BMC Med. 2024 Jun 20;22(1):255. doi: 10.1186/s12916-024-03477-x.
5
Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.2020 - 2023年1900万成年人队列中初级保健中长新冠的临床编码:一项OpenSAFELY分析
EClinicalMedicine. 2024 May 17;72:102638. doi: 10.1016/j.eclinm.2024.102638. eCollection 2024 Jun.
6
Characterization of Post-COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study.新冠后定义及临床编码实践的特征描述:纵向研究
Online J Public Health Inform. 2024 May 3;16:e53445. doi: 10.2196/53445.
7
Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study.利用电子健康记录研究苏格兰成年人中长新冠的患病率及风险因素:一项全国性回顾性观察队列研究
EClinicalMedicine. 2024 Apr 11;71:102590. doi: 10.1016/j.eclinm.2024.102590. eCollection 2024 May.
8
Before and after COVID-19: Changes in symptoms and diagnoses in 13,033 adults.新冠前后:13033 名成年人症状和诊断的变化。
PLoS One. 2024 Mar 8;19(3):e0286371. doi: 10.1371/journal.pone.0286371. eCollection 2024.
9
Post-Viral Pain, Fatigue, and Sleep Disturbance Syndromes: Current Knowledge and Future Directions.病毒感染后疼痛、疲劳和睡眠障碍综合征:当前认知与未来方向
Can J Pain. 2024 Jan 9;7(2):2272999. doi: 10.1080/24740527.2023.2272999. eCollection 2023.
10
Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition.ICD-10 编码 U09.9 的记录率和退伍军人事务部患有新冠后状况患者的临床特征。
JAMA Netw Open. 2023 Dec 1;6(12):e2346783. doi: 10.1001/jamanetworkopen.2023.46783.